https://www.taxtmi.com/caselaws?id=797993 Bulk drugs and active pharmaceutical ingredients used to manufacture pharmaceutical formulations, or for testing, clinical research, bioavailability or bioequivalence studies, fall within "all drugs and medicines" where they are pharmaceutical substances, components of drugs and satisfy applicable regulatory requirements. The description-based concessional entry applies regardless of classification in general chemical chapters; its separate reference to formulations manufactured from bulk drugs does not restrict the entry to finished dosage forms. The specific drugs-and-medicines entry takes precedence over general chemical entries, and ambiguity in a taxing rate notification is resolved in favour of the taxpayer. Qualifying APIs attract 5% IGST, subject to individual verification that no nil-rate exclusion applies. en-us Mon, 24 Aug 2026 00:00:00 +0530 Tue, 01 Sep 2026 08:26:26 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=797993 Bulk drugs and active pharmaceutical ingredients used to manufacture pharmaceutical formulations, or for testing, clinical research, bioavailability or bioequivalence studies, fall within "all drugs and medicines" where they are pharmaceutical substances, components of drugs and satisfy applicable regulatory requirements. The description-based concessional entry applies regardless of classification in general chemical chapters; its separate reference to formulations manufactured from bulk drugs does not restrict the entry to finished dosage forms. The specific drugs-and-medicines entry takes precedence over general chemical entries, and ambiguity in a taxing rate notification is resolved in favour of the taxpayer. Qualifying APIs attract 5% IGST, subject to individual verification that no nil-rate exclusion applies. Case-Laws Customs Mon, 24 Aug 2026 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=797993